Soleno Therapeutics Stock Slumps After Scorpion Capital Reveals Short Position: But Retail’s Not Pessimistic Yet

MSN
2025.08.15 18:26
portai
I'm PortAI, I can summarize articles.

Soleno Therapeutics（SLNO）的股價在 Scorpion Capital 披露其空頭頭寸後下跌了 7%，報告強調了與其用於普拉德 - 威利綜合症的藥物 Vykat XR 相關的風險。該報告引發了對潛在的前糖尿病/糖尿病、肺水腫及其他健康問題的擔憂。儘管如此，散户投資者對該股票的未來仍持樂觀態度

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.